文献速递癫痫

成人 vs 儿童原发性全面性强直-阵挛发作药物疗效的荟萃分析

Meta-analysis of drug efficacy in adult vs pediatric trials of patients with PGTC seizures.
PubMed 文献 · Neurology · 2020-04-01

该荟萃分析比较了抗癫痫药物在成人及2-12岁儿童原发性全面性强直-阵挛发作(PGTCS)中的疗效。纳入7项辅助治疗试验,拉莫三嗪和托吡酯的效应量在成人与儿童间一致;儿童发作频率中位降低50.0%-79.7%,成人57.0%-64.0%。结论支持用成人试验的药物反应预测2-12岁儿童的 comparable 疗效。

要点

  • 拉莫三嗪和托吡酯在成人与2-12岁儿童PGTCS中效应量一致。
  • 儿童发作频率中位降低50.0%-79.7%,成人57.0%-64.0%。
  • 托吡酯研究≥50%应答率儿童50%、成人58%,两者相似。

核心结论

  • 本荟萃分析支持使用成人抗癫痫药物临床试验中的药物反应来预测2-12岁PGTCS儿童的可比治疗反应。

研究设计与样本

  • 对EMBASE、Medline和Cochrane Central Register of Controlled Trials中成人及2-12岁儿童PGTCS临床试验进行电子检索的荟萃分析。
  • 由神经科医生采用标准化检索和评估选择合格试验,共纳入7项成人与儿童辅助治疗PGTCS试验。

主要发现

  • 拉莫三嗪和托吡酯的效应量在成人与儿童间一致。
  • 儿童发作频率中位降低范围为50.0%至79.7%,成人为57.0%至64.0%。
  • 托吡酯研究中≥50%应答率儿童为50%,成人为58%,两者相似。

关键数值与推荐

  • 采用基线后发作频率中位降低百分比和≥50%应答率比较成人与儿童药物疗效。

临床怎么用

  • 成人PGTCS试验中拉莫三嗪和托吡酯的疗效数据可用于预估2-12岁儿童的 comparable 治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A meta-analysis of published studies was performed to determine whether the efficacy of antiseizure drugs in adults with primary generalized tonic-clonic seizures (PGTCS) is comparable with that in the pediatric population (2-12 years of age). METHODS: Electronic searches were conducted in EMBASE, Medline, and the Cochrane Central Register of Controlled Trials for clinical trials of PGTCS in adults and children 2-12 years of age. Neurologists used standardized search and study evaluations to select eligible trials. Median percent reduction in seizure frequency from baseline and ≥50% responder rates were used to compare drug efficacy in adults and children. RESULTS: Among 7 adjunctive-therapy PGTCS trials in adults and children (2-12 years of age) that met evaluation criteria, effect sizes were consistent between adults and children for lamotrigine and topiramate. The baseline-subtracted median percent seizure reduction in seizure frequency ranged from 50.0% to 79.7% in children and 57.0% to 64.0% in adults. The ≥50% responder rate was similar between children and adults in a topiramate study (50% in children compared with 58% in adults). CONCLUSIONS: This meta-analysis supports the use of drug response from antiseizure drug clinical trials for PGTCS in adults to predict comparable treatment response in children 2-12 years of age with PGTCS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nordli DR, Bagiella E, Arzimanoglou A, et al. Meta-analysis of drug efficacy in adult vs pediatric trials of patients with PGTC seizures. Neurology. 2020. PMID: 32238509. doi:10.1212/WNL.0000000000009325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。